You just read:

Oncolytics Biotech® to Present Clinical Findings of Pelareorep-Induced Immune Response in Breast Tumors at the ESMO Breast Cancer Virtual Meeting

News provided by

Oncolytics Biotech Inc.

May 04, 2020, 07:00 ET